JP Morgan Chase’s Adagio Medical Holdings ADGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-975
Closed -$1.05K 8167
2026
Q1
$1.05K Buy
+975
New +$989 ﹤0.01% 7113
2025
Q2
Sell
-100,000
Closed -$79.5K 7780
2025
Q1
$79.5K Hold
100,000
﹤0.01% 5676
2024
Q4
$105K Buy
+100,000
New +$241K ﹤0.01% 5742

Other funds holding ADGM

JP Morgan Chase's ADGM Position: Q2 2026 in Review

JP Morgan Chase sold out of Adagio Medical Holdings (ADGM) in Q2 2026, closing a stake of 975 shares — an estimated $1.05K sold.

JP Morgan Chase first reported a position in ADGM in Q4 2024 and held it in 3 quarters. The position peaked at $105K in Q4 2024. 12 funds tracked by Wall St. Rank hold ADGM as of Q2 2026.

  • JP Morgan Chase reported no remaining Adagio Medical Holdings position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 975 Adagio Medical Holdings shares in Q2 2026, an estimated $1.05K.
  • JP Morgan Chase first reported a position in Adagio Medical Holdings in Q4 2024 and held it in 3 quarters.
  • JP Morgan Chase's Adagio Medical Holdings position peaked at $105K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Adagio Medical Holdings as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.